Viewing Study NCT06382168


Ignite Creation Date: 2025-12-24 @ 5:59 PM
Ignite Modification Date: 2026-03-27 @ 6:09 PM
Study NCT ID: NCT06382168
Status: RECRUITING
Last Update Posted: 2025-09-03
First Post: 2024-04-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Delta-Fly Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module